We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
- Authors
Vasey, Paul A; Jayson, Gordon C; Gordon, Alan; Gabra, Hani; Coleman, Rob; Atkinson, Ronnie; Parkin, David; Paul, James; Hay, Andrea; Kaye, Stan B; Scottish Gynaecological Cancer Trials Group
- Abstract
Chemotherapy with a platinum agent and a taxane (paclitaxel) is considered the standard of care for treatment of ovarian carcinoma. We compared the combination of docetaxel-carboplatin with the combination of paclitaxel-carboplatin as first-line chemotherapy for stage Ic-IV epithelial ovarian or primary peritoneal cancer.
- Publication
Journal of the National Cancer Institute, 2004, Vol 96, Issue 22, p1682
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djh323